Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 6 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Opus Genetics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 40 | 1 | 41 | +2 |
| Shares | 2.17M | 41 | 2.07M | −101.1K (−4.7%) |
| Value | $8.07M | $0 | $6.69M | −$1.38M (−17.1%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Opus Genetics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ameriprise Financial Inc | 29,848 | $97.0K | 0.00% |
| Bank of Montreal | 15,600 | $68.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 14,000 | $45.0K | 0.00% |
| Powell Investment Advisors, LLC | 13,500 | $44.0K | 0.03% |
| Simplex Trading, LLC | 10,243 | $33.0K | 0.00% |
| Kestra Private Wealth Services, LLC | 10,000 | $32.0K | 0.00% |
| MCF Advisors LLC | 9,499 | $31.0K | 0.00% |
| Spire Wealth Management | 9,002 | $29.0K | 0.00% |
| Captrust Financial Advisors | 1,500 | $5.00K | 0.00% |
| Citigroup Inc | 66 | $0 | 0.00% |
Sold out (8)
Institutions that held Opus Genetics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Millennium Management LLC | 47,431 | $177.0K |
| Renaissance Technologies LLC | 19,361 | $72.0K |
| LPL Financial LLC | 15,004 | $56.0K |
| Squarepoint Ops LLC | 10,655 | $40.0K |
| Byrne Asset Management LLC | 2,176 | $8.00K |
| Group One Trading, L.P. | 790 | $3.00K |
| Tower Research Capital LLC (TRC) | 1 | $0 |
| Cornerstone Advisory, LLC | 1 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 41 | $0 |